Resources
The latest in biomarkers research, from development and diagnostics to precision medicine
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarkers for Drug Discovery & Development
TruCulture@: Whole blood collection and culture system for clinical studies
Biomarkers for Drug Discovery & Development
Multiplex Immunoassays for Idiopathic Pulmonary Fibrosis
Biomarkers for Drug Discovery & Development
Nu.Q Discover: Streamlining Drug Development with Non-Invasive, Real-Time, Quantitative, Liquid Biopsy Immunoassays
Biomarkers for Drug Discovery & Development
Immunoassays to bring your neurodegenerative therapeutics to market
Biomarkers for Drug Discovery & Development
Biomarker Discovery and the Identification of the First Cancer Biomarker
In modern healthcare, biomarkers are an integral part of approaches to monitoring patient health and condition, providing researchers with a means of predicting treatment response. But what was the first biomarker to be discovered?
Biomarkers for Drug Discovery & Development
High-Throughput Biomarker Discovery for Clinical Trial Optimization
On-Demand Webinar featuring Dr Mo Jain, Founder & CEO of Sapient
This webinar shares how next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data are being leveraged for robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
This webinar shares how next-generation, high throughput mass spectrometry, advanced data analysis, and population-scale data are being leveraged for robust discovery of biomarkers that can be used to align patients, disease biology, and therapeutic interventions for clinical trials.
Biomarkers for Drug Discovery & Development
Selection Biomarkers: Shaping the Future of Drug Development and Regulatory Approval
While constraints on the integration of NGS approaches in selection biomarker validation for new treatments still need ironing out, their benefits in assisting clinical trial progress are undeniable.
Biomarkers for Drug Discovery & Development
The Potential Uses of AI in Biomarker Discovery and Biomarker Validation
With efforts already being made to apply artificial intelligence to imaging data for improved biomarker validation, AI is here to stay. However, to truly streamline drug development it needs to be implemented practically.
Biomarkers for Drug Discovery & Development
Bioassay Optimisation: How the Pandemic Reshaped International Standards for New Therapeutics
The global race to develop, trial, and distribute a vaccine for Covid-19 may have permanently accelerated the development of future therapeutics, including treatments for cancer.
Biomarkers for Drug Discovery & Development
New Therapeutic Target for Aggressive Breast Cancer
Scientists at VCU Massey Cancer Center pinpoint druggable target in aggressive breast cancer.
Biomarkers for Drug Discovery & Development
Treating the Untreatable: Unlocking Precision Medicine Biomarkers for NASH
Introducing PreciNASH, a multidisciplinary consortium strengthening the link between research outputs and clinical applications in NASH disease treatment.
Biomarkers for Drug Discovery & Development
What’s Next for Predictive Biomarkers in Immunotherapy?
From maximising immune response with combination biomarkers to conducting diagnostic innovation in immunotherapy prognosis, the future of predictive biomarkers is fast approaching. We speak to senior representatives from industry and academia to find out more.
Biomarkers for Drug Discovery & Development
Developing a biomarker? Keep these 3 takeaways in mind
Three key take aways when you develop biomarkers: one during biomarker discovery, one during biomarker development and one during biomarker validation.
Biomarkers for Drug Discovery & Development
The 5 most common pitfalls when developing biomarkers
Discovering a strong biomarker is an expensive and time-consuming process. One of the key takeaways is to take your time and look at the data before you start testing for biomarkers.
Biomarkers for Drug Discovery & Development
The future of biomarkers: where are they heading?
Biomarkers come in many shapes and sizes. It’s an ever-evolving subject with many under-discovered possibilities. Let’s look at some ways biomarkers are looking to evolve.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers